| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Influenza in Birds | 14 | 2021 | 528 | 2.97 | Why? |
| Zika Virus | 11 | 2018 | 1924 | 2.64 | Why? |
| Zika Virus Infection | 8 | 2018 | 1920 | 1.71 | Why? |
| Influenza A Virus, H7N9 Subtype | 10 | 2021 | 415 | 1.66 | Why? |
| Viral Envelope Proteins | 18 | 2021 | 3539 | 1.55 | Why? |
| Recombination, Genetic | 5 | 2021 | 1265 | 1.45 | Why? |
| Influenza A virus | 8 | 2018 | 2234 | 1.24 | Why? |
| Chiroptera | 9 | 2021 | 3530 | 1.18 | Why? |
| SARS Virus | 21 | 2020 | 13021 | 1.13 | Why? |
| T-Lymphocytes, Cytotoxic | 4 | 2017 | 552 | 1.12 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 15 | 2020 | 8843 | 1.11 | Why? |
| Poultry | 7 | 2021 | 437 | 1.10 | Why? |
| Glycoproteins | 3 | 2017 | 615 | 1.06 | Why? |
| Host Specificity | 6 | 2021 | 926 | 1.06 | Why? |
| Receptors, Virus | 10 | 2021 | 5659 | 1.03 | Why? |
| Hemorrhagic Fever, Ebola | 8 | 2019 | 1475 | 1.03 | Why? |
| Herpesvirus 1, Suid | 2 | 2017 | 18 | 0.88 | Why? |
| Viral Vaccines | 14 | 2021 | 7560 | 0.88 | Why? |
| HLA-A Antigens | 5 | 2019 | 196 | 0.86 | Why? |
| Epitopes, T-Lymphocyte | 7 | 2019 | 2262 | 0.84 | Why? |
| Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2019 | 11 | 0.82 | Why? |
| Models, Molecular | 18 | 2020 | 7616 | 0.81 | Why? |
| Ribonucleoproteins | 2 | 2018 | 151 | 0.80 | Why? |
| Crystallography, X-Ray | 19 | 2021 | 2689 | 0.80 | Why? |
| Influenza, Human | 19 | 2021 | 10779 | 0.80 | Why? |
| Rodentia | 1 | 2021 | 235 | 0.79 | Why? |
| 4-1BB Ligand | 1 | 2018 | 9 | 0.78 | Why? |
| Animals | 72 | 2021 | 78931 | 0.78 | Why? |
| HLA-G Antigens | 1 | 2019 | 48 | 0.78 | Why? |
| Spike Glycoprotein, Coronavirus | 26 | 2021 | 37182 | 0.77 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2018 | 41 | 0.77 | Why? |
| Protein Binding | 24 | 2021 | 11430 | 0.75 | Why? |
| Pseudorabies | 2 | 2017 | 13 | 0.75 | Why? |
| Influenza A Virus, H5N2 Subtype | 1 | 2018 | 15 | 0.74 | Why? |
| Dipeptidyl Peptidase 4 | 3 | 2017 | 1061 | 0.74 | Why? |
| Phylogeny | 24 | 2021 | 13341 | 0.74 | Why? |
| Cross-Linking Reagents | 1 | 2018 | 91 | 0.73 | Why? |
| Poultry Diseases | 3 | 2018 | 588 | 0.73 | Why? |
| Livestock | 2 | 2018 | 184 | 0.71 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 5 | 2018 | 511 | 0.71 | Why? |
| Nectins | 1 | 2017 | 8 | 0.71 | Why? |
| Coronavirus | 10 | 2021 | 18339 | 0.71 | Why? |
| Testicular Diseases | 1 | 2018 | 35 | 0.71 | Why? |
| Evolution, Molecular | 9 | 2021 | 3691 | 0.70 | Why? |
| Marburgvirus | 1 | 2017 | 71 | 0.67 | Why? |
| Reassortant Viruses | 6 | 2018 | 287 | 0.66 | Why? |
| Ebolavirus | 7 | 2018 | 834 | 0.65 | Why? |
| Phlebovirus | 1 | 2017 | 106 | 0.63 | Why? |
| Severe Acute Respiratory Syndrome | 10 | 2017 | 12361 | 0.63 | Why? |
| Repetitive Sequences, Amino Acid | 2 | 2013 | 37 | 0.62 | Why? |
| Capsid Proteins | 2 | 2018 | 365 | 0.60 | Why? |
| Viral Nonstructural Proteins | 6 | 2020 | 4810 | 0.60 | Why? |
| Adenoviridae | 2 | 2021 | 1151 | 0.60 | Why? |
| Sexually Transmitted Diseases, Viral | 1 | 2017 | 115 | 0.60 | Why? |
| Virus Physiological Phenomena | 1 | 2017 | 155 | 0.59 | Why? |
| Infertility, Female | 1 | 2017 | 150 | 0.59 | Why? |
| Amino Acid Sequence | 16 | 2021 | 6049 | 0.59 | Why? |
| Communicable Diseases, Emerging | 8 | 2018 | 2523 | 0.59 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.58 | Why? |
| Genome, Viral | 16 | 2021 | 13157 | 0.58 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.54 | Why? |
| Rift Valley Fever | 3 | 2019 | 39 | 0.53 | Why? |
| Viral Proteins | 10 | 2021 | 7370 | 0.53 | Why? |
| Cryoelectron Microscopy | 3 | 2021 | 2372 | 0.53 | Why? |
| Rift Valley fever virus | 3 | 2019 | 48 | 0.53 | Why? |
| Swine | 5 | 2018 | 3352 | 0.53 | Why? |
| Membrane Glycoproteins | 9 | 2006 | 2273 | 0.52 | Why? |
| Immunoglobulins | 1 | 2019 | 811 | 0.52 | Why? |
| Nucleocapsid Proteins | 5 | 2020 | 3120 | 0.50 | Why? |
| China | 38 | 2021 | 50654 | 0.50 | Why? |
| Zoonoses | 5 | 2018 | 3034 | 0.49 | Why? |
| Antigen Presentation | 4 | 2019 | 524 | 0.49 | Why? |
| Testis | 1 | 2018 | 566 | 0.48 | Why? |
| Infertility, Male | 1 | 2017 | 322 | 0.48 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2017 | 482 | 0.47 | Why? |
| Birds | 4 | 2019 | 412 | 0.46 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.45 | Why? |
| Virus Attachment | 3 | 2019 | 1259 | 0.43 | Why? |
| Binding Sites | 13 | 2021 | 6201 | 0.43 | Why? |
| Viral Tropism | 2 | 2017 | 1329 | 0.43 | Why? |
| Protein Conformation | 14 | 2020 | 4386 | 0.42 | Why? |
| Swine Diseases | 3 | 2017 | 1219 | 0.42 | Why? |
| T-Lymphocytes | 6 | 2019 | 6670 | 0.41 | Why? |
| Streptococcal Infections | 2 | 2014 | 255 | 0.41 | Why? |
| Histocompatibility Antigens Class I | 3 | 2019 | 624 | 0.41 | Why? |
| Bacteria | 2 | 2018 | 1897 | 0.39 | Why? |
| Coronaviridae Infections | 1 | 2013 | 442 | 0.38 | Why? |
| Molecular Sequence Data | 8 | 2017 | 3198 | 0.38 | Why? |
| Mycobacterium tuberculosis | 2 | 2019 | 1164 | 0.38 | Why? |
| Communicable Diseases, Imported | 1 | 2017 | 843 | 0.38 | Why? |
| Protein Structure, Secondary | 7 | 2018 | 1077 | 0.37 | Why? |
| Protein Multimerization | 3 | 2021 | 1336 | 0.37 | Why? |
| Sf9 Cells | 2 | 2020 | 273 | 0.37 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.37 | Why? |
| Antibodies, Monoclonal | 7 | 2021 | 8041 | 0.36 | Why? |
| Mice, Inbred BALB C | 11 | 2021 | 5814 | 0.36 | Why? |
| Mice | 19 | 2021 | 21357 | 0.36 | Why? |
| Genetic Variation | 7 | 2018 | 3919 | 0.36 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.36 | Why? |
| Epitopes | 5 | 2021 | 4113 | 0.36 | Why? |
| Virus Diseases | 4 | 2018 | 3779 | 0.35 | Why? |
| Coronavirus Infections | 27 | 2021 | 253789 | 0.35 | Why? |
| Antibodies, Neutralizing | 14 | 2021 | 25288 | 0.35 | Why? |
| Sequence Alignment | 7 | 2021 | 2109 | 0.34 | Why? |
| Small Ubiquitin-Related Modifier Proteins | 1 | 2006 | 11 | 0.34 | Why? |
| Influenza A Virus, H5N8 Subtype | 2 | 2018 | 50 | 0.34 | Why? |
| Vaccines, Subunit | 3 | 2021 | 1088 | 0.34 | Why? |
| Virus Internalization | 7 | 2021 | 7921 | 0.34 | Why? |
| Ubiquitin-Conjugating Enzymes | 1 | 2006 | 27 | 0.33 | Why? |
| Viral Matrix Proteins | 2 | 2018 | 1243 | 0.33 | Why? |
| Epitope Mapping | 2 | 2017 | 1240 | 0.32 | Why? |
| Humans | 105 | 2021 | 930598 | 0.32 | Why? |
| Genomics | 2 | 2020 | 3118 | 0.32 | Why? |
| Bunyaviridae Infections | 2 | 2018 | 107 | 0.32 | Why? |
| Yellow fever virus | 2 | 2018 | 205 | 0.31 | Why? |
| Epidemics | 4 | 2020 | 6407 | 0.31 | Why? |
| Disease Outbreaks | 13 | 2021 | 27595 | 0.30 | Why? |
| Animals, Wild | 3 | 2018 | 1028 | 0.30 | Why? |
| Protein Domains | 8 | 2021 | 6563 | 0.30 | Why? |
| Escherichia coli Infections | 1 | 2009 | 348 | 0.30 | Why? |
| Terminology as Topic | 2 | 2021 | 546 | 0.29 | Why? |
| Rotavirus | 2 | 2018 | 329 | 0.28 | Why? |
| Conserved Sequence | 3 | 2017 | 751 | 0.28 | Why? |
| DNA Fragmentation | 1 | 2004 | 67 | 0.28 | Why? |
| Antigens, Viral | 3 | 2020 | 6298 | 0.28 | Why? |
| Ubiquitin | 1 | 2006 | 243 | 0.28 | Why? |
| Viral Core Proteins | 1 | 2004 | 134 | 0.27 | Why? |
| Models, Statistical | 2 | 2021 | 5312 | 0.26 | Why? |
| Viral Fusion Proteins | 5 | 2004 | 399 | 0.26 | Why? |
| B7-H1 Antigen | 2 | 2018 | 541 | 0.26 | Why? |
| HEK293 Cells | 6 | 2021 | 8394 | 0.25 | Why? |
| Cell Line | 9 | 2021 | 12040 | 0.25 | Why? |
| Orthomyxoviridae Infections | 3 | 2019 | 1001 | 0.25 | Why? |
| Travel | 4 | 2021 | 7220 | 0.25 | Why? |
| Peptides | 8 | 2019 | 2513 | 0.24 | Why? |
| Circular Dichroism | 5 | 2017 | 154 | 0.24 | Why? |
| Peptide Fragments | 3 | 2010 | 2075 | 0.24 | Why? |
| Vaccines, DNA | 4 | 2017 | 871 | 0.24 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.24 | Why? |
| Chickens | 5 | 2018 | 1010 | 0.24 | Why? |
| Antibodies, Viral | 18 | 2021 | 51949 | 0.24 | Why? |
| Membrane Fusion | 4 | 2017 | 713 | 0.24 | Why? |
| Immunity, Cellular | 3 | 2015 | 3614 | 0.24 | Why? |
| Shrews | 1 | 2021 | 28 | 0.24 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2004 | 635 | 0.23 | Why? |
| Pan troglodytes | 2 | 2021 | 157 | 0.23 | Why? |
| Tandem Repeat Sequences | 1 | 2021 | 78 | 0.23 | Why? |
| Sierra Leone | 2 | 2019 | 267 | 0.23 | Why? |
| Drug Resistance, Viral | 2 | 2018 | 1083 | 0.22 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.22 | Why? |
| Lymphocyte Activation | 3 | 2019 | 2742 | 0.22 | Why? |
| Host-Pathogen Interactions | 7 | 2021 | 11041 | 0.21 | Why? |
| Gene Transfer, Horizontal | 2 | 2018 | 64 | 0.21 | Why? |
| Vaccination | 6 | 2021 | 19050 | 0.21 | Why? |
| Amino Acid Motifs | 4 | 2018 | 620 | 0.21 | Why? |
| RNA-Binding Proteins | 2 | 2018 | 1022 | 0.21 | Why? |
| Structural Homology, Protein | 2 | 2019 | 149 | 0.21 | Why? |
| Chemokine CCL7 | 1 | 2020 | 39 | 0.21 | Why? |
| Disease Reservoirs | 3 | 2020 | 1672 | 0.21 | Why? |
| Cross-Priming | 1 | 2019 | 9 | 0.21 | Why? |
| Influenza A Virus, H5N1 Subtype | 2 | 2017 | 492 | 0.20 | Why? |
| Spodoptera | 1 | 2020 | 220 | 0.20 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.20 | Why? |
| Viruses | 3 | 2018 | 2238 | 0.20 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.20 | Why? |
| Vaccines, Inactivated | 2 | 2017 | 1562 | 0.20 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.20 | Why? |
| Marek Disease | 1 | 2018 | 5 | 0.20 | Why? |
| Protein Interaction Domains and Motifs | 2 | 2020 | 2134 | 0.20 | Why? |
| Genes, MHC Class I | 1 | 2019 | 81 | 0.20 | Why? |
| Leukocytes, Mononuclear | 3 | 2020 | 2115 | 0.20 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2020 | 358 | 0.20 | Why? |
| Enzyme-Linked Immunospot Assay | 2 | 2017 | 325 | 0.19 | Why? |
| Neuraminidase | 5 | 2019 | 289 | 0.19 | Why? |
| Murine hepatitis virus | 3 | 2004 | 1720 | 0.19 | Why? |
| beta-Defensins | 1 | 2018 | 38 | 0.19 | Why? |
| Diptera | 1 | 2018 | 30 | 0.19 | Why? |
| Arylsulfonates | 1 | 2018 | 2 | 0.19 | Why? |
| Vero Cells | 6 | 2021 | 14117 | 0.19 | Why? |
| Central Nervous System Protozoal Infections | 1 | 2018 | 16 | 0.19 | Why? |
| Bunyaviridae | 1 | 2018 | 22 | 0.19 | Why? |
| Naegleria fowleri | 1 | 2018 | 23 | 0.19 | Why? |
| Sequence Analysis, DNA | 6 | 2018 | 2830 | 0.19 | Why? |
| Macaca | 1 | 2020 | 388 | 0.18 | Why? |
| Orthobunyavirus | 1 | 2018 | 53 | 0.18 | Why? |
| Hepatitis B, Chronic | 2 | 2018 | 616 | 0.18 | Why? |
| Thogotovirus | 1 | 2017 | 4 | 0.18 | Why? |
| Cells, Cultured | 4 | 2020 | 5835 | 0.18 | Why? |
| Hepatitis B Core Antigens | 1 | 2018 | 76 | 0.18 | Why? |
| Binding, Competitive | 1 | 2018 | 264 | 0.18 | Why? |
| Molecular Biology | 1 | 2021 | 139 | 0.18 | Why? |
| Zanamivir | 1 | 2018 | 63 | 0.18 | Why? |
| Crystallization | 3 | 2017 | 331 | 0.18 | Why? |
| Oligosaccharides | 1 | 2018 | 69 | 0.18 | Why? |
| HLA-A2 Antigen | 2 | 2010 | 134 | 0.18 | Why? |
| Charadriiformes | 1 | 2017 | 14 | 0.18 | Why? |
| Lipid Droplets | 1 | 2018 | 75 | 0.17 | Why? |
| Double-Blind Method | 2 | 2021 | 5988 | 0.17 | Why? |
| Cell-Free Nucleic Acids | 1 | 2021 | 271 | 0.17 | Why? |
| Case Management | 1 | 2020 | 285 | 0.17 | Why? |
| Animal Migration | 1 | 2017 | 49 | 0.17 | Why? |
| Histocompatibility Antigen H-2D | 1 | 2016 | 21 | 0.17 | Why? |
| Anseriformes | 1 | 2017 | 32 | 0.17 | Why? |
| Pandemics | 16 | 2021 | 389249 | 0.17 | Why? |
| Disease Transmission, Infectious | 3 | 2020 | 9044 | 0.17 | Why? |
| Transfection | 1 | 2020 | 864 | 0.17 | Why? |
| Nanospheres | 1 | 2017 | 34 | 0.17 | Why? |
| Rotavirus Infections | 2 | 2018 | 355 | 0.17 | Why? |
| Protein Structure, Tertiary | 4 | 2013 | 1565 | 0.17 | Why? |
| Immunomagnetic Separation | 1 | 2017 | 55 | 0.16 | Why? |
| Hemagglutinins | 1 | 2017 | 143 | 0.16 | Why? |
| Vaccines, Virus-Like Particle | 2 | 2017 | 312 | 0.16 | Why? |
| Amino Acid Substitution | 3 | 2020 | 1706 | 0.16 | Why? |
| Ebola Vaccines | 1 | 2017 | 126 | 0.16 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 382 | 0.16 | Why? |
| Antiviral Agents | 13 | 2020 | 41703 | 0.16 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.16 | Why? |
| Peptides, Cyclic | 1 | 2018 | 223 | 0.16 | Why? |
| Single-Chain Antibodies | 1 | 2018 | 259 | 0.15 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2020 | 691 | 0.15 | Why? |
| Sialic Acids | 1 | 2017 | 218 | 0.15 | Why? |
| Chemokine CXCL10 | 1 | 2020 | 565 | 0.15 | Why? |
| Recombinant Proteins | 4 | 2020 | 3786 | 0.15 | Why? |
| Glycosylation | 2 | 2017 | 1255 | 0.15 | Why? |
| Arginine | 1 | 2018 | 377 | 0.15 | Why? |
| Blood Group Antigens | 1 | 2018 | 202 | 0.15 | Why? |
| Histocompatibility Antigens Class II | 1 | 2018 | 383 | 0.15 | Why? |
| Acinetobacter Infections | 1 | 2018 | 273 | 0.15 | Why? |
| Orthomyxoviridae | 2 | 2021 | 1168 | 0.15 | Why? |
| Acinetobacter baumannii | 1 | 2018 | 378 | 0.15 | Why? |
| Biological Evolution | 2 | 2017 | 641 | 0.14 | Why? |
| Interferon-gamma Release Tests | 1 | 2017 | 253 | 0.14 | Why? |
| Mice, Transgenic | 3 | 2021 | 2739 | 0.14 | Why? |
| Ecology | 1 | 2016 | 140 | 0.14 | Why? |
| Genes, Viral | 2 | 2017 | 1428 | 0.14 | Why? |
| Streptococcus suis | 1 | 2014 | 8 | 0.14 | Why? |
| Geography | 2 | 2018 | 1801 | 0.14 | Why? |
| Receptors, Cell Surface | 1 | 2019 | 586 | 0.14 | Why? |
| Reproduction | 1 | 2017 | 259 | 0.14 | Why? |
| Surface Plasmon Resonance | 1 | 2016 | 440 | 0.14 | Why? |
| Aedes | 1 | 2018 | 380 | 0.14 | Why? |
| Ligands | 1 | 2019 | 1300 | 0.14 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 572 | 0.13 | Why? |
| Sequence Homology, Amino Acid | 3 | 2013 | 945 | 0.13 | Why? |
| MicroRNAs | 2 | 2021 | 1787 | 0.13 | Why? |
| Apoptosis | 1 | 2004 | 2335 | 0.13 | Why? |
| Phylogeography | 1 | 2018 | 824 | 0.13 | Why? |
| Alphacoronavirus | 1 | 2018 | 392 | 0.13 | Why? |
| Vaccines, Synthetic | 3 | 2021 | 3231 | 0.13 | Why? |
| Cell Line, Tumor | 2 | 2020 | 3608 | 0.13 | Why? |
| Alleles | 1 | 2019 | 1557 | 0.13 | Why? |
| Structure-Activity Relationship | 2 | 2017 | 2219 | 0.12 | Why? |
| Cyclin G1 | 1 | 2012 | 2 | 0.12 | Why? |
| HIV Infections | 1 | 2019 | 11620 | 0.12 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.12 | Why? |
| Drug Design | 3 | 2020 | 2627 | 0.12 | Why? |
| Ferrets | 1 | 2019 | 1201 | 0.12 | Why? |
| Female | 29 | 2021 | 380317 | 0.12 | Why? |
| Erythrocytes | 1 | 2018 | 617 | 0.12 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.12 | Why? |
| Electrochemical Techniques | 1 | 2017 | 406 | 0.12 | Why? |
| DNA, Viral | 3 | 2020 | 2521 | 0.12 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.12 | Why? |
| Immunodominant Epitopes | 1 | 2017 | 813 | 0.12 | Why? |
| High-Throughput Nucleotide Sequencing | 3 | 2020 | 3633 | 0.12 | Why? |
| Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.12 | Why? |
| Genome, Archaeal | 1 | 2011 | 6 | 0.12 | Why? |
| Genomic Islands | 1 | 2011 | 26 | 0.12 | Why? |
| Dog Diseases | 1 | 2019 | 745 | 0.12 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.12 | Why? |
| Archaea | 1 | 2011 | 30 | 0.11 | Why? |
| RNA Viruses | 1 | 2019 | 824 | 0.11 | Why? |
| Emigration and Immigration | 1 | 2017 | 501 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.11 | Why? |
| RNA, Viral | 10 | 2021 | 32276 | 0.11 | Why? |
| Adult | 19 | 2021 | 244371 | 0.11 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.11 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.11 | Why? |
| Male | 23 | 2021 | 367725 | 0.11 | Why? |
| Down-Regulation | 2 | 2021 | 1416 | 0.11 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2018 | 11367 | 0.11 | Why? |
| Methyltransferases | 1 | 2017 | 720 | 0.11 | Why? |
| Middle East | 1 | 2016 | 1418 | 0.11 | Why? |
| Influenza Vaccines | 2 | 2017 | 2941 | 0.11 | Why? |
| Polysaccharides | 1 | 2018 | 854 | 0.10 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.10 | Why? |
| Escherichia coli O157 | 1 | 2009 | 26 | 0.10 | Why? |
| Streptococcus | 1 | 2009 | 76 | 0.10 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2017 | 830 | 0.10 | Why? |
| Global Health | 5 | 2021 | 13911 | 0.10 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2012 | 310 | 0.10 | Why? |
| RNA, Messenger | 3 | 2021 | 5131 | 0.10 | Why? |
| Recombinant Fusion Proteins | 2 | 2004 | 919 | 0.10 | Why? |
| Protein Folding | 1 | 2010 | 270 | 0.10 | Why? |
| Protein Structure, Quaternary | 1 | 2010 | 455 | 0.09 | Why? |
| Disease Models, Animal | 5 | 2018 | 10998 | 0.09 | Why? |
| Adjuvants, Immunologic | 2 | 2017 | 1709 | 0.09 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.09 | Why? |
| Cross Reactions | 2 | 2017 | 4374 | 0.09 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.09 | Why? |
| CHO Cells | 2 | 2020 | 831 | 0.09 | Why? |
| Hydrogen Bonding | 1 | 2010 | 599 | 0.09 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.09 | Why? |
| Cricetulus | 2 | 2020 | 936 | 0.09 | Why? |
| Glutathione Transferase | 2 | 2004 | 86 | 0.09 | Why? |
| Genome, Bacterial | 1 | 2011 | 446 | 0.09 | Why? |
| Respiratory Tract Diseases | 1 | 2016 | 1061 | 0.09 | Why? |
| Hemagglutinins, Viral | 2 | 2019 | 176 | 0.08 | Why? |
| Hemagglutination Inhibition Tests | 2 | 2017 | 191 | 0.08 | Why? |
| Intracellular Fluid | 1 | 2006 | 9 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.08 | Why? |
| Carrier Proteins | 1 | 2010 | 513 | 0.08 | Why? |
| Two-Hybrid System Techniques | 1 | 2006 | 116 | 0.08 | Why? |
| Cytokines | 5 | 2020 | 15010 | 0.08 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2018 | 9335 | 0.08 | Why? |
| Enzyme Inhibitors | 1 | 2017 | 1881 | 0.08 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2020 | 2984 | 0.08 | Why? |
| Escherichia coli | 3 | 2020 | 1547 | 0.08 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.08 | Why? |
| Microscopy, Electron, Transmission | 2 | 2020 | 605 | 0.08 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.08 | Why? |
| Republic of Korea | 2 | 2016 | 5858 | 0.08 | Why? |
| HeLa Cells | 2 | 2021 | 1303 | 0.08 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.07 | Why? |
| Mice, Inbred C57BL | 2 | 2021 | 5542 | 0.07 | Why? |
| Sequence Homology | 2 | 2018 | 448 | 0.07 | Why? |
| Chromatography, Gel | 1 | 2004 | 71 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.07 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.07 | Why? |
| Saudi Arabia | 1 | 2016 | 4423 | 0.07 | Why? |
| Child | 6 | 2021 | 70012 | 0.07 | Why? |
| Hydrogen-Ion Concentration | 4 | 2017 | 993 | 0.07 | Why? |
| Genetic Vectors | 3 | 2021 | 1600 | 0.07 | Why? |
| Selection, Genetic | 2 | 2019 | 691 | 0.07 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.07 | Why? |
| Immunochemistry | 1 | 2004 | 95 | 0.07 | Why? |
| Molecular Weight | 1 | 2004 | 249 | 0.07 | Why? |
| Hepatitis B virus | 1 | 2012 | 882 | 0.07 | Why? |
| Ecosystem | 1 | 2009 | 776 | 0.07 | Why? |
| Rabbits | 2 | 2020 | 1171 | 0.07 | Why? |
| Chromatin | 1 | 2004 | 107 | 0.07 | Why? |
| Molecular Epidemiology | 1 | 2009 | 1638 | 0.06 | Why? |
| Staining and Labeling | 1 | 2004 | 169 | 0.06 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.06 | Why? |
| Infant, Newborn | 3 | 2019 | 23105 | 0.06 | Why? |
| Endopeptidases | 1 | 2003 | 228 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Dogs | 2 | 2021 | 2529 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 7868 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.06 | Why? |
| Fluorescence | 1 | 2004 | 475 | 0.06 | Why? |
| Drug Discovery | 1 | 2016 | 3092 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Cell Nucleus | 1 | 2004 | 399 | 0.06 | Why? |
| Mutation | 5 | 2021 | 12376 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Microscopy, Electron | 1 | 2004 | 830 | 0.06 | Why? |
| Infant | 3 | 2019 | 30274 | 0.06 | Why? |
| Protein Engineering | 1 | 2004 | 536 | 0.06 | Why? |
| Linoleic Acid | 1 | 2021 | 65 | 0.05 | Why? |
| Asia | 2 | 2019 | 2399 | 0.05 | Why? |
| Virulence | 2 | 2019 | 2172 | 0.05 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Saliva | 1 | 2017 | 4679 | 0.05 | Why? |
| Substrate Specificity | 2 | 2018 | 639 | 0.05 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 2309 | 0.05 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.05 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 13720 | 0.05 | Why? |
| Child, Preschool | 3 | 2019 | 36283 | 0.05 | Why? |
| Computer Graphics | 1 | 2021 | 124 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.05 | Why? |
| Immunity, Humoral | 1 | 2014 | 4849 | 0.05 | Why? |
| Feathers | 1 | 2018 | 5 | 0.05 | Why? |
| Multiprotein Complexes | 1 | 2020 | 182 | 0.05 | Why? |
| Limit of Detection | 2 | 2018 | 2698 | 0.05 | Why? |
| Oligosaccharides, Branched-Chain | 1 | 2018 | 11 | 0.05 | Why? |
| Hemagglutination | 1 | 2018 | 36 | 0.05 | Why? |
| Injections, Intramuscular | 1 | 2021 | 800 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Geese | 1 | 2018 | 29 | 0.05 | Why? |
| Viral Load | 5 | 2018 | 15850 | 0.05 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.05 | Why? |
| Ducks | 1 | 2018 | 120 | 0.05 | Why? |
| Magnetics | 1 | 2018 | 66 | 0.05 | Why? |
| HLA-B Antigens | 1 | 2019 | 166 | 0.04 | Why? |
| Hemorrhagic Fever with Renal Syndrome | 1 | 2018 | 31 | 0.04 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2016 | 5837 | 0.04 | Why? |
| Drug Delivery Systems | 2 | 2020 | 1365 | 0.04 | Why? |
| Baculoviridae | 1 | 2017 | 132 | 0.04 | Why? |
| Temperature | 2 | 2004 | 2305 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2021 | 1008 | 0.04 | Why? |
| Angola | 1 | 2017 | 75 | 0.04 | Why? |
| Insecta | 1 | 2017 | 122 | 0.04 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2018 | 159 | 0.04 | Why? |
| Amino Acids | 1 | 2021 | 552 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2021 | 1132 | 0.04 | Why? |
| Mitochondria | 1 | 2004 | 857 | 0.04 | Why? |
| Guinea Pigs | 1 | 2018 | 420 | 0.04 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Dendritic Cells | 1 | 2005 | 1330 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Protein Transport | 1 | 2018 | 487 | 0.04 | Why? |
| Databases, Protein | 1 | 2021 | 523 | 0.04 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.04 | Why? |
| Coma | 1 | 2018 | 204 | 0.04 | Why? |
| Bird Diseases | 1 | 2018 | 130 | 0.04 | Why? |
| Molecular Conformation | 1 | 2017 | 374 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Africa, Western | 1 | 2017 | 363 | 0.04 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2018 | 610 | 0.04 | Why? |
| Interferon-gamma | 1 | 2006 | 2711 | 0.04 | Why? |
| Fatal Outcome | 2 | 2018 | 3438 | 0.04 | Why? |
| Luminescence | 1 | 2017 | 236 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 2017 | 391 | 0.04 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.04 | Why? |
| Mutation Rate | 1 | 2018 | 382 | 0.04 | Why? |
| Quantum Dots | 1 | 2017 | 129 | 0.04 | Why? |
| Immunization | 2 | 2015 | 2019 | 0.04 | Why? |
| Static Electricity | 1 | 2017 | 397 | 0.04 | Why? |
| Yellow Fever | 1 | 2018 | 231 | 0.04 | Why? |
| Aged | 8 | 2020 | 215776 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2018 | 907 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.04 | Why? |
| Primates | 1 | 2018 | 584 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 1 | 2004 | 3776 | 0.03 | Why? |
| Epidemiologic Studies | 1 | 2017 | 554 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2021 | 1182 | 0.03 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.03 | Why? |
| Fluorescent Dyes | 1 | 2018 | 536 | 0.03 | Why? |
| Oseltamivir | 1 | 2018 | 583 | 0.03 | Why? |
| Cats | 1 | 2021 | 1890 | 0.03 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.03 | Why? |
| United States | 1 | 2021 | 46150 | 0.03 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2014 | 393 | 0.03 | Why? |
| Lung | 2 | 2020 | 31049 | 0.03 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2019 | 760 | 0.03 | Why? |
| RNA | 1 | 2021 | 1278 | 0.03 | Why? |
| Gastroenteritis | 1 | 2018 | 489 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Macaca fascicularis | 1 | 2017 | 1009 | 0.03 | Why? |
| Antibody Specificity | 1 | 2017 | 1328 | 0.03 | Why? |
| Dimerization | 2 | 2004 | 475 | 0.03 | Why? |
| Computational Biology | 2 | 2021 | 4514 | 0.03 | Why? |
| DNA Primers | 1 | 2017 | 1170 | 0.03 | Why? |
| DNA, Archaeal | 1 | 2011 | 7 | 0.03 | Why? |
| Gold | 1 | 2017 | 592 | 0.03 | Why? |
| Blotting, Western | 1 | 2014 | 863 | 0.03 | Why? |
| Nose | 1 | 2019 | 1093 | 0.03 | Why? |
| Molecular Docking Simulation | 2 | 2018 | 6902 | 0.03 | Why? |
| HIV | 1 | 2019 | 1116 | 0.03 | Why? |
| Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
| Gene Expression Regulation, Viral | 1 | 2018 | 925 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2017 | 881 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.03 | Why? |
| Catalytic Domain | 1 | 2018 | 1757 | 0.03 | Why? |
| Disease Notification | 1 | 2017 | 639 | 0.03 | Why? |
| Pharynx | 1 | 2019 | 1544 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.03 | Why? |
| Chemokines | 1 | 2017 | 1095 | 0.03 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Kinetics | 1 | 2018 | 3238 | 0.02 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.02 | Why? |
| ABO Blood-Group System | 1 | 2018 | 995 | 0.02 | Why? |
| Time Factors | 4 | 2018 | 31397 | 0.02 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2005 | 6537 | 0.02 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2015 | 1316 | 0.02 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.02 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| DNA, Bacterial | 1 | 2011 | 835 | 0.02 | Why? |
| Cluster Analysis | 1 | 2015 | 3001 | 0.02 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Methylprednisolone | 1 | 2017 | 2107 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.02 | Why? |
| Carboxypeptidases | 1 | 2005 | 148 | 0.02 | Why? |
| Immunologic Memory | 1 | 2017 | 3362 | 0.02 | Why? |
| Neutralization Tests | 1 | 2019 | 6698 | 0.02 | Why? |
| Macaca mulatta | 1 | 2015 | 3716 | 0.02 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 238 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2018 | 4155 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Hospitalization | 3 | 2017 | 54280 | 0.02 | Why? |
| X-Ray Diffraction | 1 | 2004 | 249 | 0.02 | Why? |
| Amino Acid Chloromethyl Ketones | 1 | 2003 | 62 | 0.02 | Why? |
| Histidine | 1 | 2003 | 72 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Solubility | 1 | 2004 | 382 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Communication | 1 | 2021 | 5206 | 0.02 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Biosensing Techniques | 1 | 2017 | 2116 | 0.01 | Why? |
| Cysteine | 1 | 2003 | 238 | 0.01 | Why? |
| Models, Chemical | 1 | 2003 | 332 | 0.01 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.01 | Why? |
| Cloning, Molecular | 1 | 2004 | 1036 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Immunoassay | 1 | 2016 | 4485 | 0.01 | Why? |
| Blood Cell Count | 1 | 2005 | 1101 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Ribavirin | 1 | 2005 | 1182 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.01 | Why? |
| Colorectal Neoplasms | 1 | 2012 | 1884 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| T-Lymphocyte Subsets | 1 | 2005 | 1387 | 0.01 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.01 | Why? |
| Liver | 1 | 2012 | 4007 | 0.01 | Why? |
| Base Sequence | 1 | 2005 | 3581 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Cysteine Endopeptidases | 1 | 2003 | 1557 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2017 | 23402 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Computer Simulation | 1 | 2004 | 4982 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Models, Biological | 1 | 2004 | 4907 | 0.01 | Why? |